Vaxart VXRT
OTC VXRT
$0.48 -0.01 (-1.94%)
As of: Oct 21, 2026 · 12:16 PM EDT

Vaxart (VXRT) Short-Term Debt repayments (2018)

Updated

Vaxart (VXRT) reported Short-Term Debt repayments of $102,000 for Q4 2018, up 100.0% from the prior quarter.

Analysis

Vaxart (VXRT) Short-Term Debt repayments (2018) Analysis & Trends

For FY2018, Vaxart posted Short-Term Debt repayments of $214,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ST Debt Repayment (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 6.45 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Vaxart 115.76 Mn 51.76 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 102,000.00
Sep 30, 2018 51,000.00
API Access

Vaxart Short-Term Debt repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt-repayments&ticker=VXRT&period=max&api_key=YOUR_API_KEY